Psychological and Neuropsychological Testing Criteria
Customize your policy alerts
Sign up for lucet Policy 20.5.004 alerts
Get alerted when Policy 20.5.004 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity criteria, limitations, and expectations for psychological and neuropsychological testing for members covered under Lucet plans; applies to providers requesting or performing these assessments.
No material clinical or coverage changes in this revision.
Medical Necessity Criteria
inv-01: Psychological Testing - Medically Necessary
Psychological testing considered medically necessary when ONE OR MORE of the following needs are present:
Covers items A.1–A.9 from policy.
inv-02: Neuropsychological Testing - Medically Necessary
Neuropsychological testing considered medically necessary when ONE OR MORE of the following needs are present:
Covers items B.1–B.4 from policy; includes assessment over time when clinically indicated.
Psychological and neuropsychological testing is not considered reasonable and necessary when used as routine screening or for non-clinical purposes. Examples include administration to general populations without a documented clinical justification, or testing performed solely for educational, vocational, or other non-medical purposes that do not inform medical or health management. Testing that is comprised exclusively of self-administered, self-created, or self-scored inventories, or comprised exclusively of screening instruments (for example, the AIMS or the Folstein Mini-Mental Status Examination) is also excluded from coverage as routine/non-clinical use.
Testing is not reasonable and necessary when the patient cannot participate meaningfully in the testing process (for example, due to neurological, cognitive, or psychological impairment) or when there is no reasonable expectation that the results will change medical or psychological management. Coverage is also excluded for tests administered while the patient is under the undue influence of alcohol or drugs, or while experiencing acute delirium or psychosis. Repeat testing requested without clinical justification is likewise considered not necessary.
Provider Responsibilities and Documentation
Prior Authorization and Coding Adherence
Prior authorization is required when benefits are available for psychological or neuropsychological testing. Tests must be billed consistent with CPT and APA billing guidance; follow payer prior authorization processes and obtain approval before scheduling when the member's contract provides coverage.
- Prior authorization required when benefits available
- Adhere to CPT definitions for screening, psychological, neuropsychological tests, technician use, and machine-administered tests
- Follow APA billing and coding guidance
Step Therapy
No step therapy requirements are specified for psychological or neuropsychological testing in this policy.
Required Documentation
A comprehensive report is required at completion of testing. The report must list the tests administered, scores, normative data used, and provide an in-depth summary of findings. The proposed battery must be individualized to address specific diagnostic/clinical questions, be standardized with nationally accepted validity and reliability, and include tests appropriate for the member's age, culture, primary language, and developmental level.
- Comprehensive report including tests used, scores, normative data, and detailed interpretation
- Battery individualized to diagnostic/clinical questions from initial assessment
- Tests must be standardized with accepted validity/reliability
- Normative data and suitability for member's age, culture, language, and developmental level
Assessment Documentation
An initial face-to-face complete diagnostic assessment is required prior to testing. Results must be expected to contribute to development and implementation of an individualized treatment plan, and the assessment should define the specific diagnostic questions the testing battery will address.
- Initial face-to-face complete diagnostic assessment required
- Assessment must identify diagnostic/clinical questions guiding the test battery
- Testing results expected to inform individualized treatment planning
Denial and Redundant Testing Triggers
Testing is not reasonable and necessary when the patient cannot participate meaningfully, will not benefit from results to guide medical or psychological management, or when testing is routine screening, for non-clinical purposes, solely self-administered/self-scored, or when performed under acute intoxication, delirium, or psychosis. Deny when testing will not change management or duplicates prior definitive testing without expectation of new clinical impact.
- Denial triggers: inability to participate, lack of expected therapeutic or management benefit, inappropriate testing purpose
- Redundant testing: prior definitive diagnosis (e.g., known dementia) with no expectation testing will alter care
- Do not cover routine screening in absence of clinical justification or testing solely for educational/vocational purposes
Billing Codes and Coding Guidance
| 96130 | Psychological testing evaluation services — (example; document references adherence to CPT code definitions) |
| 96131 | Psychological testing evaluation services with interpretation and report — (example) |
| 96132 | Neuropsychological testing evaluation services — (example) |
| 96133 | Neuropsychological testing evaluation services with interpretation and report — (example) |
| 96136 | Psychological or neuropsychological test administration by technician |
| 96137 | Psychological or neuropsychological test administration by technician with interpretation |
| 96138 | Psychological or neuropsychological testing using a device (computerized) |
| 96139 | Psychological or neuropsychological testing using a device with interpretation |
Clinical Background
Psychological and neuropsychological testing are clinical assessments intended to evaluate functioning and to inform diagnosis, prognosis, and treatment planning. Psychological testing assesses psychiatric symptoms, functional strengths and limitations, risk, motivation, and other factors that influence treatment and care. Neuropsychological testing evaluates cognitive and neurobehavioral functioning for known or suspected central nervous system conditions (for example, traumatic brain injury, neurodegenerative disease, developmental disorders), and is used to measure impairments, guide treatment or rehabilitation, and assess capacity to participate in medical or surgical interventions.
This policy applies when testing is ordered to assist clinical decision-making — for example, to determine diagnosis or symptom severity, differentiate disorders with overlapping presentations, evaluate the cognitive impact of a medical condition or treatment, conduct pre-surgical cognitive assessment, design or monitor cognitive rehabilitation, measure deficits affecting development in children and adolescents, or evaluate attention and concentration symptoms. Testing performed without a clinical rationale or when results will not inform care is excluded under the limitations described above.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.